1-4 of 4
Fengjuan Lu
Close
Sort by
Journal Articles

Improved Outcome of Newly Diagnosed Childhood Mature B-Cell Lymphoma/Leukemia with High Tumor Burden Treated with BFM95-Based Protocol Combining Rituximab: A Report from Shanghai, China

Yang Fu, MBBS, Hongsheng Wang, MD, Xiaowen Zhai, MD PhD, Xiaowen Qian, MD, Jianhua Meng, MD, Hui Miao, MD, Xiaohua Zhu, MD PhD, Yi Yu, MD, Fengjuan Lu, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4162.
https://doi.org/10.1182/blood.V130.Suppl_1.4162.4162
Published: 2017
Journal Articles

HLA Disparity Is Associated with Improved Outcomes in Hematological Malignancies After Family HLA-Mismatched /Haploidentical HCT but Not URD

Lujia Dong, M.D., Zhi-Yong Gao, M.D., Xin-Jian Yu, M.D., Xi-You Tan, M.D., Jin-Hong Liu, M.D., Fengjuan Lu, M.D., Yi Xie, M.D., Lung-Ji Chang, PhD, Ling Zhou, M.D., Wen-Rong Lu, M.D., Can Tong, M.D., Yuan-Ying Zeng, M.D., Shuang Hou, M.D., Na Xu, M.D., Xue Yan, M.S., Dao-Pei Lu, M.D.
Journal: Blood
Blood (2012) 120 (21): 2014.
https://doi.org/10.1182/blood.V120.21.2014.2014
Published: 2012
Journal Articles

The Incidence and Outcome of Acute Lymphoblastic Leukemia in Shanghai, China Over 5 Years (2002–2006)

Xiong Ni, Zhixiang Shen, Fangyuan Chen, Hui Liang, Fengjuan Lu, Jingyan Tang, Chun Wang, Jingbo Shao, Jian Hou, Shanhua Zou, Jianmin Wang
Journal: Blood
Blood (2008) 112 (11): 3946.
https://doi.org/10.1182/blood.V112.11.3946.3946
Published: 2008
Journal Articles

P 0 -Related Protein Accelerates the Migration of Human Mesenchymal Stem Cells and Their Progeny by Modulating VLA-5 Interactions with Fibronectin.

Suzanne M. Watt, PhD, MRCPath, Maria Roubelakis, D.Phil, Sinead Forde, BSc, Fengjuan Lu, MSc, Grigorios Tsaknakis, BSc, Enca Martin-Rendon, PhD
Journal: Blood
Blood (2006) 108 (11): 1391.
https://doi.org/10.1182/blood.V108.11.1391.1391
Published: 2006